loading page

Amplatzer Amulet™ Left Atrial Appendage Occluder: A Step-By-Step Guide to Device Implantation
  • Christopher Ellis
Christopher Ellis
Vanderbilt University Medical Center

Corresponding Author:[email protected]

Author Profile


Recently receiving FDA approval, the Amplatzer Amulet™ LAA occluder device (Abbott Medical Inc) provides a dual seal mechanism alternative to the commercially available Watchman FLX or Watchman 2.5 device for embolic stroke prevention in patients with non-valvular atrial fibrillation (NVAF). This Step-by-Step review will cover patient selection, pre-procedure imaging assessment, device sizing, device preparation, implant target position assessment, implant technique and troubleshooting, and immediate post implant follow-up.
21 Jan 2022Submitted to Journal of Cardiovascular Electrophysiology
24 Jan 2022Submission Checks Completed
24 Jan 2022Assigned to Editor
24 Jan 2022Reviewer(s) Assigned
28 Jan 2022Review(s) Completed, Editorial Evaluation Pending
28 Jan 2022Editorial Decision: Revise Minor
31 Jan 20221st Revision Received
01 Feb 2022Submission Checks Completed
01 Feb 2022Assigned to Editor
01 Feb 2022Reviewer(s) Assigned
02 Feb 2022Review(s) Completed, Editorial Evaluation Pending
02 Feb 2022Editorial Decision: Accept
28 Feb 2022Published in Journal of Cardiovascular Electrophysiology. 10.1111/jce.15420